Gujarat Themis Biosyn approves issuance of Non-Convertible Debentures up to ₹585 Cr
Gujarat Themis Biosyn · Pharmaceuticals & Biotechnology
Key highlights
- Board approved private placement issuance of NCDs aggregating up to ₹585 Crores
- NCDs will not be listed on any stock exchange
- Further details like allotment date, maturity, interest rate, and security will be disclosed later
Why it's rated notable: The Board approved a limit of INR 585 Crores for NCD issuance, which is above ₹500 crore and large next to annual revenue of ₹174 crore and market value of ₹4,673 crore, though tenure, coupon and security are yet to be disclosed.
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Board Meeting Outcome for Outcome Of The Board Meeting Held On 10.09.2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Gujarat Themis Biosyn
- Fundraise / allotmentNotableGujarat Themis Biosyn Limited announces dividend, fund raise, and AOA amendment
- Fundraise / allotmentNotableGujarat Themis Biosyn Ltd allots ₹585 crore NCDs via private placement on 16-09-2026
- Fundraise / allotmentNotableGujarat Themis Biosyn Limited closes QIP, approves 2,11,86,440 shares at ₹354 each
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentImagicaaworld EntertainmentImagicaaworld Entertainment reports Q2 & H1 FY27 financial results and strategic updates
- Fundraise / allotmentUnited Heat TransferUnited Heat Transfer Limited approves half-year financial results for Sept 2026
- Fundraise / allotmentJubilant PharmovaJubilant Pharmova reports Q2 and H1 FY27 financial results and operational updates
- Fundraise / allotmentNatural CapsulesNatural Capsules Limited approves Q2 2026 results and preferential allotment
- Fundraise / allotmentNatural CapsulesNatural Capsules Ltd announces Q2 FY27 results and approves preferential allotment
- Fundraise / allotmentDestiny Logistics & InfraDestiny Logistics & Infra Ltd announces key resignations, appointments, and warrant lapse
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.